A B S T R A C T Previous studies have suggested that there is an overproduction of triiodothyronine (T3) relative to thyroxine (T4) in patients with thyrotoxicosis associated with Graves' disease. To evaluate whether or not an increased ratio of T3 to T4 in thyroidal secretion couild be contributing to this relative T3 hyperproduction, T3, T4, and iodine were measured in thyroglobulin (Tg) from controls and patients with Graves' disease who had been treated either with propranolol only or with antithyroid drugs plus iodide before surgery. To avoid possible artifacts associated with pulse labeling and chromatography, T3 and T4 were determined by radioimmunoassay of Pronase hydrolysates of purified Tg. Results of analyses of Tg from six control patients and seven with Graves' disease, not receiving thiourea drugs or iodide, showed that the iodine content of Graves' disease Tg was not different from normal. Both contained 3.4 residtues of T4lmolecule Tg, but there was 0.39+0.08 (mean+SD) residue of TJImolecule Tg in Graves' Tg as opposed to 0.23+0.07 residue T3 molectule Tg in controls matched for iodine content (P < 0.01). This difference restulted in a significantly lower T4/T3 molar ratio (9+2) in Graves' Tg as opposed to control (15±+2, P<0.001). In Tg from patients with treated Graves' disease, iodine, T3, and T4 were reduced, buit the reduction in the latter was more stubstantial, restulting in a T4/T3 molar ratio of 3.4 ± 1. Fractionation of Tg from all grouips by RbCl density gradient uiltracentrifugation indicated that at physiological levels of Tg iodination, the molar ratio of T3/Tg was consistently higher in Graves' disease.
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Dr. Larsen is an Investigator of the Howard Hughes Medical Institute. Received for publication 7 October 1976 and in revised form 7 February 1977. known, but it is not due to iodine deficiency. If T3 and T4 are secreted in this altered ratio in patients with Graves' disease, the magnitude of the difference could explain the relative T3 hyperproduction which is characteristic of this state.
INTRODUCTION
There is considerable evidence that the hyperthyroidism associated with Graves' disease is accompanied by hyperproduction of triiodothyronine (T3)' relative to thyroxine (T4) (1) . The most extreme example of this phenomenon is found in the patient with the clinical stigmata of hyperthyroidism, a normal serum T4 and elevated serum T3, a condition which has been called "T3 thyrotoxicosis" (2) . Previous studies from our laboratory have suggested that the contribution of direct thyroidal secretion to the peripheral T3 pool in thyrotoxicosis is greater than in the euthyroid subject (3, 4) . Studies of digests of thyroid homogenates from nonnal subjects and patients with treated Graves' disease showed that the molar ratio of T3 to T4 in the thyroid glands of patients with treated Graves' disease was higher than in normal subjects (4) . However, because of the pretreatment of these subjects with antithyroid agents, iodine content was reduced. Since reduction in iodine content per se gives rise to thyroglobulin (Tg) with an increased T/T4 molar ratio (5), it was not possible to determine if the high T3/T4 ratio was due to Graves' disease or iodine deficiency itself. Preliminary data obtained in homogenates of thyroid tisstue from two patients who were treated only with propranolol before therapy showed only a modest reduction in iodine content, but a marked increase in the TJT4 ratio (4 (8) . A model L Beckman preparative centrifuge with SW 50.1 rotor was tused (Beckman Instniments, Inc., Spinco Div., Palo Alto, Calif.) and centrifuigation was performed for 5-7 days at 20°C at 33,000 rpm. Fractionation was obtained tusing the Buchler Auto Densi-Flow II C apparatus (Buchler Instruiments Div., Searle Analytic Inc., Fort Lee, N. J.). 35 0.15-0.2-ml fractions were obtained from each tube. After protein quiantitation, appropriate fractions were pooled and dialyzed against 500 ml of 0.04 M Tris-0.11 M NaCI, pH 8.5 for three 2-h periods to remove RbCl. Measurements of iodine content and Pronase digestion were then performed.
Digestion of Tg. 20-40 jig of purified Tg (either after gel filtration or RbCl equilibrium centriftigation) in TrisNaCl was placed in a small plastic titbe and digested according to the method of Inoue and Taurog (9) . In addition to 100 ,ul of the Tg solution, each ttube contained 30 gl of 0.15 M 1-methyl-2-mercaptoimidazole, (Aldrich Chemical Co. Milwaukee, Wis.) and 20 ,ul of' Pronase (B grade Calbiochem San Diego, Calif.) 3 mg/ml in Tris NaCl with 10 ,ul toluene. Incubation was carried out for 24 h at 37°C tinder N2. Completeness of digestion was determined by quantitation of iodine remaining at the origin of a butanol-acetic acid chromatogram of unextracted digests of Tg from three control and three propranolol-treated patients. The appearance of 1-during digestion (also in six samples) was determined by (quantitation of iodine in the appropriate area of the chromatographic strip (butanol-acetic acid) as indicated by the location of 1251 which had been added in tracer amouints. The digests were extracted with 0.8 ml methanol/concentrated ammoniuim hydroxide (99/1, vol/vol). Appropriate dilutions of this extract were made and radioimmunoassay of T3 and T4 performed in dtuplicate at two dilutions uising minor modifications of methods previously described (10) . Specimens from all controls and all Graves' thyroids were assayed simultaneously to avoid interassay variation. Iodine determinations were performed by Boston Medical Laboratory. Statistical comparisons were carried out uising methods described by Snedecor and Cochran or, where indicated, by Fisher's Exact Treatment (11, 12) .
RESULTS
Clinical data for subjects with Graves' disease. In Table I are presented the presurgical therapy and biochemical restults relative to thyroid statuis of the patients with Graves' disease. The resuilts of the first seven patients who received propranolol alone are typical of patients with untreated hyperthyroidism due to Graves' disease. T3 determinations were available in only two patients and both were elevated.
were also caleulated excluding subjects 1 Ats typical elution patterns of Tg from euthyroid a by-product, then it is theoretically possible that tients and those with propranolol-treated Graves' greater deiodination of T4 to T3 could occur with disease. Aside from differences in the width of the peak associated with the degree of column loading, there was no apparent difference in elution patterns between these two groups of samples. In all subjects the 19S peak was clearly delineated and constituted the greatest percentage of the protein present.
Measurements of T3, T4, and iodine, in Tg from control subjects are presented in Table II . The mean iodine content of the group was 0.42% corresponding to 22 atoms of iodine/molecule Tg. The content of T3 and T4 per molecule Tg was 0.18 and 2.5 with a calculated molar ratio of 13. When expressed as a percentage of the total Tg iodine, this corresponds to 2.4 and 41% for T3 and T4, respectively. The iodine content of two of the control Tg preparations was modestly reduced for reasons which were not apparent from the clinical history. In subject 1 this was associated with a T4 content which appeared to be considerably below that of the remainder of the group. Because of the reduced iodine content, and because of the fact that, as will be seen in Table III , the Graves' disease Tg was relatively rich in iodine, mean values of Tg obtained using this technique are presented in Fig. 2 . As with the gel-filtration elution profile, there appeared to be no significant difference between the pattern in Graves' disease and that of controls. After determination of protein concentration, the fractions were pooled into four groups, A-D, as indicated by the lines in Fig. 2 . Iodine determinations and Pronase digestion were performed on the pooled subfractions. The iodine content of the four fractions followed a consistent pattern. It was lowest in the A fraction, and reached a peak in fraction C, while that of the B fraction was intermediate. The iodine content of the D fraction was the same or slightly lower than that of the C fraction. The data presented in Table IV shows the efficiency of this separation technique analyzed by comparing the Tg iodine content of the A and C fractions. In addition, the T4/T3 ratios calculated for the Tg in the same fractions are also presented. In the control specimens, the mean number of iodine atoms per molecule Tg was 14 in the A fractions whereas in the C fractions it was 19. These values are significantly different and demonstrate the successful partition of the Tg ijiolecules according to iodine content. A larger gradient is seen in the Graves' disease Tg where the iodine/Tg ratio was 13 in the A fractions and 24 in the C fractions. Despite the significant differences in iodine content of the Tg from the A and C fractions, the molar ratio of T4/T3 was not different, either in the normals, or in the patients with Graves' disease. Thus, it appeared that the T4T3 molar ratio was in- dependent of the iodination of the Tg within a single gland as it was partitioned in these studies. T3Tg and T4/Tg in RbCl subfractions. The separation of Tg into four subfractions allowed an analysis of the relationship between the T3 and T4 and iodination of the Tg over a broad range of iodine content. There were 23 subfractions of normal Tg and 40 subfractions of Tg from treated and untreated patients with Graves' disease. Figs. 3-5 show the relationship between the TJTg, T4ITg, and T./T3 molar ratios and iodine content for all subfractions. In Fig. 3 , there appears to be a higher T/Tg ratio in Graves' disease Tg at any level of iodine content. The T3/Tg ratio was significantly higher in the propranololtreated Graves' patients as opposed to control subjects with P = 0.003 by the Fisher's Exact Treatment (12) . On the other hand, there was a great overlap between the controls and Graves disease groups in the T4/Tg molar ratios (Fig. 4) . As was the case with the analyses of the whole Tg preparations (Table III) , the T4/T3 molar ratios in the RbCl subfractions were significantly higher in normal Tg than in Tg from patients with propranolol-treated Graves' disease (P = 0.013, Fisher's Extract Treatment). These results are presented in Fig. 5 . DISCUSSION Much of the previous data in the literature relative to the iodothyronine content of human thyroid tissue or Tg is derived from studies obtained using tissue from patients treated preoperatively with labeled iodine. In this method, the thyroid tissue was then digested and labeled compounds were separated by chromatography with iodine content being measured in each fraction. There are two technical problems with this analytical approach for T3 and T4 determinations. The first is that chromatography generally results in deiodination of T4 with some of this appearing as T3 artifactually increasing the T3/T4 ratio (13, 14) . Secondly, tracer iodine given on a single occasion within a few days of surgery is not homogeneously distributed within the thyroid gland. Heterogeneity, both with respect to the iodination of Tg within a follicle as well as between follicles in various portions of the thyroid gland has been clearly demonstrated (15, 16) . The radioimmunoassay tech- (20) . Our previous studies gave results of 13 and 11 for T4/T3 ratio in homogenates of normal htuman thyroids (4, 21) .
The iodine content ofthe Tg from seven propranololtreated patients with Graves' disease was normal. Because the usual approach to presurgical therapy of patients with this disease includes antithyroid drugs and iodine, there have been no recent systematic studies of tissue from subjects who have not received agents known to alter thyroid function. In one series, a mean value of 0.17% was found in six apparently untreated patients living in France (18) . Whether this lower value results from differences in methodology or in the iodine content of the patients' diet is unknown. The percent T4 iodine in that report varied between 7 and 49% depending on the iodine content of the Tg. This was similar to normal Tg in that study, but the data was insufficient to allow valid comparisons with the T3 content of normal Tg. The present studies indicate that the percent Tg iodine as T4 in these subjects is 49%, not different from that in normal Tg. The percent T3 iodine was significantly increased resulting in a reduction in the molar ratio of T4/T3 to 9/1. This percent T3 iodine is about 1.7 times that which we found in normal Tg.
The results presented in Fig. 3 indicate that at all levels of iodination which are present in these human Tg samples, the T3/Tg ratio is higher in the Graves' disease Tg than in the control material.
Because there is little difference in the T4ITg molar ratio (Fig. 4) , the calculated T4/T3 ratio is significantly lower in Graves' disease. The uniformity of these observations in the RbCl subfractions of differing iodine content (Fig. 5) Thyroid peroxidase has been demonstrated to have a stimulatory catalytic action on the rate of coupling of diiodotyrosine to T4 in vitro (23) . The activity of this enzyme has been recently reported to be three to fouir times normal in thyroid tissues from patients with Graves' disease (24) . It is conceivable that in Graves' disease, coupling of critical iodotyrosyl residtues might occur before their attaining the level of iodination which wouild be anticipated from the available iodine stupply. Thus instead of 2-diiodotyrosyl residues combining to form T4, earlier coupling might involve a mono-and a diiodotyrosine giving rise to T3. An iodine-independent stimtilatory effect of thyroid-stimulating hormone on couipling has been demonstrated in hypophysectomized rats by Greer et al. (25) and in thyroid-stimulating hormone-treated guinea pigs by Dunn and Ray (26) . Whether or not thyroidal peroxidase is involved in this stimulation is unclear, but the Graves' disease thyroid is clearly stimulated by some factor. It would not appear that propranolol, which appears to have no effect either on thyroidal iodine metabolism or the serum concentrations of thyroid hormones in patients with hyperthyroidism could be implicated in this effect (27, 28) .
Ouir previouis measurements of serum T3 and T4 in patients with hyperthyroidism due to Graves' disease have indicated that the mean total serum T3 concentration is 4.3 times normal and that of T4, 2.7 times normal (3). The molar ratio of T4/T3 in the serum of normal subjects was 60±3 (mean±SE) and was 40±2 in the hyperthyroid group. If this apparent relative hyperproduction of T3 is due solely to an increase in the ratio of T3/T4 in the secreted hormones, fractional peripheral T4/T3 conversion remaining unchanged, then one would predict an approximate 1.5-fold higher T3/T4 ratio in the secreted hormones. This is slightly less than the 1.7-fold difference that we observed. If the ratio of secreted hormones is similar to that present in the Tg, then this relatively small increase in the T3ITg ratio could explain the hyperproduction of T3 in patients with Grave's disease. It would also suggest that the condition known as "T3 thyrotoxicosis" is a more exaggerated form of this abnormality, perhaps influenced by the level of intrathyroidal iodine. We would conclude, therefore, that while the total quantity of the iodothyronines in the human thyroid is directly related to the iodine content of the Tg, there is another factor (or factors), one of which is present in patients with Graves' disease, which can alter the ratio of T3 to T4 present in the Tg and presumably in the secreted hormones.
